It's obvious the nameless owners of the Add Biomedical and Naturevan shares have squeezed what they can out of the shares they once had. Volume in non existant lately. The concern for me now is if the decide to make another acquisition to keep dumping on us. There has been no effort to detail the instantaneous revenue Naturevan brought after months since the acquisition and the goal of a revenue generating Add Biomedical acquisition by year end seems unattainable with the radio silence there. Concierge isn't even generating revenues higher than staff salaries and they can't seem to turn a profit on testing. Big concerns here with no answers